Page last updated: 2024-10-28

ibuprofen and Neurodevelopmental Disorders

ibuprofen has been researched along with Neurodevelopmental Disorders in 3 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).

Research Excerpts

ExcerptRelevanceReference
"To evaluate whether the presence of patent ductus arteriosus (PDA) in preterm infants worsens long-term neurodevelopmental outcomes."1.48Long-Term Neurodevelopment of Low-Birthweight, Preterm Infants with Patent Ductus Arteriosus. ( Casey, PH; Collins, RT; Gossett, JM; Lyle, RE; Rettiganti, M; Robbins, JM, 2018)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Aldecoa-Bilbao, V1
García-Catalán, MJ1
Gaixa, M1
Clotet Caba, J1
Teodoro, S1
Figaró Voltà, C1
Collins, RT1
Lyle, RE1
Rettiganti, M1
Gossett, JM1
Robbins, JM1
Casey, PH1
Bourgoin, L1
Cipierre, C1
Hauet, Q1
Basset, H1
Gournay, V1
Rozé, JC1
Flamant, C1
Gascoin, G1

Other Studies

3 other studies available for ibuprofen and Neurodevelopmental Disorders

ArticleYear
Neurodevelopmental Impairment at Two Years in Premature Infants with Prolonged Patency of Ductus Arteriosus after a Conservative Approach.
    American journal of perinatology, 2021, Volume: 38, Issue:5

    Topics: Child, Preschool; Conservative Treatment; Ductus Arteriosus, Patent; Female; Gestational Age; Humans

2021
Long-Term Neurodevelopment of Low-Birthweight, Preterm Infants with Patent Ductus Arteriosus.
    The Journal of pediatrics, 2018, Volume: 203

    Topics: Adolescent; Age Factors; Child; Child, Preschool; Cyclooxygenase Inhibitors; Ductus Arteriosus, Pate

2018
Neurodevelopmental Outcome at 2 Years of Age according to Patent Ductus Arteriosus Management in Very Preterm Infants.
    Neonatology, 2016, Volume: 109, Issue:2

    Topics: Child, Preschool; Cohort Studies; Cyclooxygenase Inhibitors; Ductus Arteriosus, Patent; Humans; Ibup

2016